Copyright Reports & Markets. All rights reserved.

Global Pharmaceutics and Novel Drug Delivery Systems Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Pharmaceutics and Novel Drug Delivery Systems Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 Liposomes
      • 1.4.3 PEGylated Proteins & Polypeptides
      • 1.4.4 Polymer Nanoparticle
      • 1.4.5 Protein–drug Conjugates
      • 1.4.6 Other
    • 1.5 Market by Application
      • 1.5.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Application: 2020 VS 2026
      • 1.5.2 Hospitals & Clinic
      • 1.5.3 Cancer Treatment Centers
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Pharmaceutics and Novel Drug Delivery Systems Market Perspective (2015-2026)
    • 2.2 Pharmaceutics and Novel Drug Delivery Systems Growth Trends by Regions
      • 2.2.1 Pharmaceutics and Novel Drug Delivery Systems Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Pharmaceutics and Novel Drug Delivery Systems Historic Market Share by Regions (2015-2020)
      • 2.2.3 Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Pharmaceutics and Novel Drug Delivery Systems Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Pharmaceutics and Novel Drug Delivery Systems Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Market Size
      • 3.1.1 Global Top Pharmaceutics and Novel Drug Delivery Systems Players by Revenue (2015-2020)
      • 3.1.2 Global Pharmaceutics and Novel Drug Delivery Systems Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Pharmaceutics and Novel Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio
      • 3.2.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Pharmaceutics and Novel Drug Delivery Systems Revenue in 2019
    • 3.3 Pharmaceutics and Novel Drug Delivery Systems Key Players Head office and Area Served
    • 3.4 Key Players Pharmaceutics and Novel Drug Delivery Systems Product Solution and Service
    • 3.5 Date of Enter into Pharmaceutics and Novel Drug Delivery Systems Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Pharmaceutics and Novel Drug Delivery Systems Historic Market Size by Type (2015-2020)
    • 4.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Type (2021-2026)

    5 Pharmaceutics and Novel Drug Delivery Systems Breakdown Data by Application (2015-2026)

    • 5.1 Global Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)
    • 5.2 Global Pharmaceutics and Novel Drug Delivery Systems Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
    • 6.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in North America (2019-2020)
    • 6.3 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
    • 6.4 North America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
    • 7.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Europe (2019-2020)
    • 7.3 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
    • 7.4 Europe Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

    8 China

    • 8.1 China Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
    • 8.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in China (2019-2020)
    • 8.3 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
    • 8.4 China Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
    • 9.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Japan (2019-2020)
    • 9.3 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
    • 9.4 Japan Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

    10 Southeast Asia

    • 10.1 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
    • 10.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Southeast Asia (2019-2020)
    • 10.3 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
    • 10.4 Southeast Asia Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

    11 India

    • 11.1 India Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
    • 11.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in India (2019-2020)
    • 11.3 India Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
    • 11.4 India Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

    12 Central & South America

    • 12.1 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size (2015-2020)
    • 12.2 Pharmaceutics and Novel Drug Delivery Systems Key Players in Central & South America (2019-2020)
    • 12.3 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Type (2015-2020)
    • 12.4 Central & South America Pharmaceutics and Novel Drug Delivery Systems Market Size by Application (2015-2020)

    13Key Players Profiles

    • 13.1 Amgen
      • 13.1.1 Amgen Company Details
      • 13.1.2 Amgen Business Overview and Its Total Revenue
      • 13.1.3 Amgen Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 13.1.4 Amgen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020))
      • 13.1.5 Amgen Recent Development
    • 13.2 Teva
      • 13.2.1 Teva Company Details
      • 13.2.2 Teva Business Overview and Its Total Revenue
      • 13.2.3 Teva Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 13.2.4 Teva Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 13.2.5 Teva Recent Development
    • 13.3 Roche
      • 13.3.1 Roche Company Details
      • 13.3.2 Roche Business Overview and Its Total Revenue
      • 13.3.3 Roche Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 13.3.4 Roche Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 13.3.5 Roche Recent Development
    • 13.4 UCB (Union Chimique Belge)
      • 13.4.1 UCB (Union Chimique Belge) Company Details
      • 13.4.2 UCB (Union Chimique Belge) Business Overview and Its Total Revenue
      • 13.4.3 UCB (Union Chimique Belge) Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 13.4.4 UCB (Union Chimique Belge) Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 13.4.5 UCB (Union Chimique Belge) Recent Development
    • 13.5 Celgene
      • 13.5.1 Celgene Company Details
      • 13.5.2 Celgene Business Overview and Its Total Revenue
      • 13.5.3 Celgene Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 13.5.4 Celgene Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 13.5.5 Celgene Recent Development
    • 13.6 Merck
      • 13.6.1 Merck Company Details
      • 13.6.2 Merck Business Overview and Its Total Revenue
      • 13.6.3 Merck Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 13.6.4 Merck Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 13.6.5 Merck Recent Development
    • 13.7 Gilead Sciences
      • 13.7.1 Gilead Sciences Company Details
      • 13.7.2 Gilead Sciences Business Overview and Its Total Revenue
      • 13.7.3 Gilead Sciences Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 13.7.4 Gilead Sciences Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 13.7.5 Gilead Sciences Recent Development
    • 13.8 Sanofi
      • 13.8.1 Sanofi Company Details
      • 13.8.2 Sanofi Business Overview and Its Total Revenue
      • 13.8.3 Sanofi Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 13.8.4 Sanofi Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 13.8.5 Sanofi Recent Development
    • 13.9 Pfizer
      • 13.9.1 Pfizer Company Details
      • 13.9.2 Pfizer Business Overview and Its Total Revenue
      • 13.9.3 Pfizer Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 13.9.4 Pfizer Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 13.9.5 Pfizer Recent Development
    • 13.10 Takeda
      • 13.10.1 Takeda Company Details
      • 13.10.2 Takeda Business Overview and Its Total Revenue
      • 13.10.3 Takeda Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 13.10.4 Takeda Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 13.10.5 Takeda Recent Development
    • 13.11 Bausch&Lomb
      • 10.11.1 Bausch&Lomb Company Details
      • 10.11.2 Bausch&Lomb Business Overview and Its Total Revenue
      • 10.11.3 Bausch&Lomb Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.11.4 Bausch&Lomb Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.11.5 Bausch&Lomb Recent Development
    • 13.12 Samyang Biopharmaceuticals
      • 10.12.1 Samyang Biopharmaceuticals Company Details
      • 10.12.2 Samyang Biopharmaceuticals Business Overview and Its Total Revenue
      • 10.12.3 Samyang Biopharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.12.4 Samyang Biopharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.12.5 Samyang Biopharmaceuticals Recent Development
    • 13.13 Johnson & Johnson
      • 10.13.1 Johnson & Johnson Company Details
      • 10.13.2 Johnson & Johnson Business Overview and Its Total Revenue
      • 10.13.3 Johnson & Johnson Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.13.4 Johnson & Johnson Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.13.5 Johnson & Johnson Recent Development
    • 13.14 TOLMAR
      • 10.14.1 TOLMAR Company Details
      • 10.14.2 TOLMAR Business Overview and Its Total Revenue
      • 10.14.3 TOLMAR Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.14.4 TOLMAR Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.14.5 TOLMAR Recent Development
    • 13.15 Astellas
      • 10.15.1 Astellas Company Details
      • 10.15.2 Astellas Business Overview and Its Total Revenue
      • 10.15.3 Astellas Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.15.4 Astellas Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.15.5 Astellas Recent Development
    • 13.16 AMAG Pharmaceuticals
      • 10.16.1 AMAG Pharmaceuticals Company Details
      • 10.16.2 AMAG Pharmaceuticals Business Overview and Its Total Revenue
      • 10.16.3 AMAG Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.16.4 AMAG Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.16.5 AMAG Pharmaceuticals Recent Development
    • 13.17 AbbVie
      • 10.17.1 AbbVie Company Details
      • 10.17.2 AbbVie Business Overview and Its Total Revenue
      • 10.17.3 AbbVie Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.17.4 AbbVie Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.17.5 AbbVie Recent Development
    • 13.18 Dr Reddy
      • 10.18.1 Dr Reddy Company Details
      • 10.18.2 Dr Reddy Business Overview and Its Total Revenue
      • 10.18.3 Dr Reddy Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.18.4 Dr Reddy Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.18.5 Dr Reddy Recent Development
    • 13.19 AstraZeneca
      • 10.19.1 AstraZeneca Company Details
      • 10.19.2 AstraZeneca Business Overview and Its Total Revenue
      • 10.19.3 AstraZeneca Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.19.4 AstraZeneca Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.19.5 AstraZeneca Recent Development
    • 13.20 Aspen
      • 10.20.1 Aspen Company Details
      • 10.20.2 Aspen Business Overview and Its Total Revenue
      • 10.20.3 Aspen Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.20.4 Aspen Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.20.5 Aspen Recent Development
    • 13.21 Acrotech Biopharma
      • 10.21.1 Acrotech Biopharma Company Details
      • 10.21.2 Acrotech Biopharma Business Overview and Its Total Revenue
      • 10.21.3 Acrotech Biopharma Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.21.4 Acrotech Biopharma Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.21.5 Acrotech Biopharma Recent Development
    • 13.22 TWi Pharmaceuticals
      • 10.22.1 TWi Pharmaceuticals Company Details
      • 10.22.2 TWi Pharmaceuticals Business Overview and Its Total Revenue
      • 10.22.3 TWi Pharmaceuticals Pharmaceutics and Novel Drug Delivery Systems Introduction
      • 10.22.4 TWi Pharmaceuticals Revenue in Pharmaceutics and Novel Drug Delivery Systems Business (2015-2020)
      • 10.22.5 TWi Pharmaceuticals Recent Development

    14Analyst's Viewpoints/Conclusions

      15Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Disclaimer

      This report focuses on the global Pharmaceutics and Novel Drug Delivery Systems status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pharmaceutics and Novel Drug Delivery Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Amgen
      Teva
      Roche
      UCB (Union Chimique Belge)
      Celgene
      Merck
      Gilead Sciences
      Sanofi
      Pfizer
      Takeda
      Bausch&Lomb
      Samyang Biopharmaceuticals
      Johnson & Johnson
      TOLMAR
      Astellas
      AMAG Pharmaceuticals
      AbbVie
      Dr Reddy
      AstraZeneca
      Aspen
      Acrotech Biopharma
      TWi Pharmaceuticals

      Market segment by Type, the product can be split into
      Liposomes
      PEGylated Proteins & Polypeptides
      Polymer Nanoparticle
      Protein–drug Conjugates
      Other
      Market segment by Application, split into
      Hospitals & Clinic
      Cancer Treatment Centers
      Others

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Pharmaceutics and Novel Drug Delivery Systems status, future forecast, growth opportunity, key market and key players.
      To present the Pharmaceutics and Novel Drug Delivery Systems development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by type, market and key regions.

      In this study, the years considered to estimate the market size of Pharmaceutics and Novel Drug Delivery Systems are as follows:
      History Year: 2015-2019
      Base Year: 2019
      Estimated Year: 2020
      Forecast Year 2020 to 2026
      For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now